Zdrowie i gospodarka · 27/01/2016

FDA Extends Comment Period for Draft Guidance on Emerging Postmarket Medical Device Signals

The FDA is extending the comment period for its draft guidance on emerging postmarket medical device signals, initially set for February 29, 2016, due to high interest from external stakeholders and the medical device community.